Physician-related factors involved in patient decisions to enroll onto cancer clinical trials.
The development of new cancer therapies requires additional, and more complex, clinical trials. But only approximately 3% to 5% of adult cancer patients participate in cancer clinical trials. This study seeks to identify and understand the attitudes of the public and cancer survivors toward health-related decisions and cancer clinical trials to identify the key factors that must be addressed to increase that percentage.
Comis
Robert L
RL
Coalition of Cancer Cooperative Groups, Philadelphia, PA; and Michigan State University, East Lansing, MI.
Miller
Jon D
JD
Colaizzi
Diane D
DD
Kimmel
Linda G
LG